Clinical Trial

A Bundled Intervention to End Opioid Overdoses

Study acronym: B-CARE
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
Opioid overdose deaths have reached historically high records in the United States and are particularly concentrated among patients after emergency department (ED) discharge. Evidence-based treatment modules to reduce repeat opioid overdose and mortality are lacking in this patient population. A bundled intervention is proposed, including telehealth, peer support specialist, buprenorphine, and linkage for definitive care, that is designed to increase treatment uptake in this patient population post-ED discharge, reduce repeat opioid overdoses, and end overdose deaths.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-03-16; most recent amendment 2026-06-16.
Trial Details
NCT Number NCT07485335
Lead Sponsor University of Alabama at Birmingham
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Opioid Use Disorder, Opioid Overdose
Enrollment 160 participants
Start Date 2026-09-07
Primary Completion 2030-09-30 (estimated)
Study Completion 2030-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-18